Correlation Between Mdica Sur and Vitro SAB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mdica Sur and Vitro SAB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mdica Sur and Vitro SAB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mdica Sur SAB and Vitro SAB de, you can compare the effects of market volatilities on Mdica Sur and Vitro SAB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mdica Sur with a short position of Vitro SAB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mdica Sur and Vitro SAB.

Diversification Opportunities for Mdica Sur and Vitro SAB

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Mdica and Vitro is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Mdica Sur SAB and Vitro SAB de in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vitro SAB de and Mdica Sur is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mdica Sur SAB are associated (or correlated) with Vitro SAB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vitro SAB de has no effect on the direction of Mdica Sur i.e., Mdica Sur and Vitro SAB go up and down completely randomly.

Pair Corralation between Mdica Sur and Vitro SAB

Assuming the 90 days trading horizon Mdica Sur SAB is expected to generate 0.86 times more return on investment than Vitro SAB. However, Mdica Sur SAB is 1.17 times less risky than Vitro SAB. It trades about 0.21 of its potential returns per unit of risk. Vitro SAB de is currently generating about -0.04 per unit of risk. If you would invest  2,850  in Mdica Sur SAB on October 12, 2024 and sell it today you would earn a total of  530.00  from holding Mdica Sur SAB or generate 18.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Mdica Sur SAB  vs.  Vitro SAB de

 Performance 
       Timeline  
Mdica Sur SAB 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Mdica Sur SAB are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak forward indicators, Mdica Sur sustained solid returns over the last few months and may actually be approaching a breakup point.
Vitro SAB de 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vitro SAB de has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Vitro SAB is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Mdica Sur and Vitro SAB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mdica Sur and Vitro SAB

The main advantage of trading using opposite Mdica Sur and Vitro SAB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mdica Sur position performs unexpectedly, Vitro SAB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vitro SAB will offset losses from the drop in Vitro SAB's long position.
The idea behind Mdica Sur SAB and Vitro SAB de pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency